Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Corsair Gaming
Sunnyvale, California, United Statescorsair.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Developing once-daily transdermal patch delivering treprostinil prodrug for PAH; aims to provide efficacy comparable to infusion with improved convenience/safety profile; Series B financing ($23M) closed Sept. 2023 supports advancement into clinical trials.
- Therapeutic areas
- PulmonologyCardiovascular
- Modalities
- Small molecule prodrug therapyTransdermal patch delivery system
- Industry
- Biotech
02
Partnerships
United TherapeuticsNew Rhein Healthcare Investors
Beyond the preview
Go deeper on Corsair Gaming.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Corsair Gaming.